ArticleCancer immunology, immunotherapy : CII2008

Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model.

Melissa A Barber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.